Ticker Details
Amylyx Pharmaceuticals, Inc.
IPO Date:	January 7, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 3.39%
Avg Daily Range (30 D):	$0.55 | 3.84%
Avg Daily Range (90 D):	$0.43 | 3.11%

Institutional Daily Volume
Avg Daily Volume:	1.18M
Avg Daily Volume (30 D):	1.15M
Avg Daily Volume (90 D):	1.23M

Trade Size
Avg Trade Size (Sh.):	94
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	1,635
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$1.79M
Avg Institutional Trade (90 D):	$1.89M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.34M
Avg Closing Trade (30 D):	$2.21M
Avg Closing Trade (90 D):	$2.51M
Avg Closing Volume:	159.25K

News

Feb 19, 2026 @ 8:30 AM Global Amyotrophic Lateral Sclerosis Therapeutics ... Source: Custom Market Insights

Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight

Jul 14, 2025 @ 10:26 PM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C.

Jul 8, 2025 @ 1:00 AM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C.

Oct 18, 2024 @ 11:26 AM Why Amylyx Pharmaceuticals Stock Was So Healthy Th... Source: Eric Volkman

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.79	$-.37	$-.46
Diluted EPS	$-1.79	$-.37	$-.46
Revenue	$-.67M	$M	$M
Gross Profit
Net Income / Loss	$-149.28M	$-34.39M	$-41.44M
Operating Income / Loss	$-157.34M	$-36.03M	$-42.86M
Cost of Revenue	$M	$M	$M
Net Cash Flow	$152.88M	$166.63M	$-1.68M
PE Ratio